Close
Digital Health & Ai Innovation summit 2026
APE 2026

Snapdeal launches ‘Sanjeevani’ to connect patients with potential plasma donors nationwide

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

FDA Cuts RWE Limitation in Drug,...

The FDA has confirmed through an announcement that it...

Natera Adds ctDNA-Based MRD Tests with...

In an all-stock transaction, Natera, which is the cell-free...

FDA Launches Technology-Enabled Meaningful Patient Outcomes

Technology-Enabled Meaningful Patient Outcomes – TEMPO has been launched...

Snapdeal, India’s largest value e-commerce company, today launched an initiative to connect COVID 19 patients with potential plasma donors. Using its wide reach in India across smaller towns & cities, Snapdeal has created an easy to use platform called “Sanjeevani” accessible via website and mobile app.

Patients and donors can register themselves with their mobile numbers/email ids and provide relevant information like blood group, location, age and donor recovery date. After registering, Snapdeal’s algorithm will look for relevant matches and connect patients with potential donors.

Sanjeevani was first launched to help the employees of Snapdeal find possible donors. But given that it has been especially hard to find eligible plasma donors at this time, Snapdeal has opened this platform for everyone.

Sanjeevani will also help raise awareness on the importance of plasma donation and encourage recovered COVID 19 patients to donate.

 

Latest stories

Related stories

FDA Cuts RWE Limitation in Drug, Device Application Reviews

The FDA has confirmed through an announcement that it...

Natera Adds ctDNA-Based MRD Tests with Acquisition of Foresight Diagnostics

In an all-stock transaction, Natera, which is the cell-free...

FDA Launches Technology-Enabled Meaningful Patient Outcomes

Technology-Enabled Meaningful Patient Outcomes – TEMPO has been launched...

US Healthcare Providers to Benefit from Minimum Nurse Staffing Rule Repeal

The federal government has formally withdrawn the Biden-era minimum...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »